Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs Intratympanic Glucocorticoids for ISSNHL with Vestibular Dysfunction
NCT03974867Unknown
- Sponsor
- Eye and ENT Hospital of Fudan University
- Start
- Jul 2019
- Primary completion
- Jul 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial in idiopathic sudden sensorineural hearing loss (ISSNHL) comparing Oral Prednisone with Intratympanic Methylprednisolone (2 arms). Primary endpoint: Complete recovery rates of vestibular function tests at 8 weeks. Status: unknown.
02
Drugs
prednisonemethylprednisolone
03
Conditions
idiopathic sudden sensorineural hearing loss (ISSNHL)
Beyond the preview
Go deeper on NCT03974867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03974867.